"Designing Growth Strategies is in our DNA"

Pharmacogenomics Market Size, Share & Analysis By Technology (Microarray, Polymerase Chain Reaction (PCR), Sanger Sequencing, Next-Generation Sequencing (NGS), and Others), By Application (HIV/AIDS, Cardiovascular Disease, Cancer, Tuberculosis, Alzheimer Disease, and Others), By End-user (Pharmacogenomics Service Provider, Pharmaceutical & Biotechnology Companies, and Academic & Research institutes), and Regional Forecast, 2024-2032

Region : Global | Report ID: FBI106937 | Status : Ongoing



Pharmacogenomics is a study to identify genomic response in specific drug treatment for making clinical and diagnostic decisions to further treat a person with effective variation and dosage. It aims to provide a more personalized approach to treating patients with various life-threatening diseases by determining the susceptibility of certain disease and to analyze efficacy of developed drugs.

The pharmacogenomics market growth is driven by higher adoption of target drug therapies in the geriatric patient population, higher demand for pharmacogenomics in drug development, and the predominance of chronic diseases like cardiology, neurological disorder, tuberculosis, HIV, and others. Moreover, the increasing focus of the market players on R&D launches of new products, and increasing government focus on growing accessibility of care & treatment for a patient population are expected to boost the market growth during the forecast period.

  • For instance, in 2018, according to National Centre for Biotechnology Information, pharmacogenomics was extensively used to make personalized medicine based on a patient's genetic information, which was used to build a therapeutic decision and is a huge part of drug development.

However, factors such as adverse reactions associated with drug therapies and lesser number of skilled and highly trained healthcare professionals to perform the pharmacogenomics diagnostics test are expected to negatively impact the market growth.  

Impact of COVID-19 on the Pharmacogenomics Market

The COVID-19 pandemic had a positive impact on the pharmacogenomics market globally. The sudden outbreak of the virus caused a surge in R&D for effective diagnosis and treatment of SARS-CoV-2. Pharmacogenomics plays a key role in target drug therapy development for COVID-19 treatment.

  • For instance, in February 2021, according to National Center for Biotechnology Information, the development of a new pharmacogenomics marker was helpful for drug designing for SARS-CoV-2.

The significant importance of pharmacogenomics for drug development of COVID-19 increased the demand for pharmacogenomics for effective treatment development and diagnosis of the virus.

Key Insight

  • Prevalence of Chronic Disease.

  • Key Development.

  • Technological Advancement in Pharmacogenomics.

  • Impact of COVID-19 on the pharmacogenomics market.

Analysis by Technology

On the basis of technology, the market is segmented into microarray, polymerase chain reaction (PCR), Sanger’s sequencing, next-generation sequencing (NGS), and others. The polymerase chain reaction segment is expected to hold a significant market share during the forecast period owing to its use for the amplification of a small segment of DNA.

Furthermore, Sanger’s sequencing technology is expected to grow at a significant growth rate during the forecast period due to its use in variant identification testing in pharmacogenomics clinical studies.

Analysis by Region

To gain extensive insights into the market, Request for Customization

North America accounts for a significant share of the global pharmacogenomics market. This is due to the increasing R&D investment, new product launches, and rising pharma sectors in the region.

  • In April 2021, according to a Congressional Budget Office article, drug approvals increased by 60.0%. As per the same data, each year 38 new drugs are approved in the U.S.

  • Additionally, in August 2018, Nebula Genomics announced seed funding of USD 4.3 million & collaborated with Veritas Genetics to enter into genome sequencing, creating a marketplace for genomic data.

Furthermore, Europe accounted for a considerable market share in 2021 owing to the increasing prevalence of chronic disease thus increasing the need for precision medicine in the region.

Key Players Covered

The report will include key players such as Thermo Fisher Scientific, Illumina, Inc., MedicalExpo, Twist Bioscience, BIOplastics, Analytik Jena GmbH, Agilent, Bio-Rad Laboratories, Inc., Promega Corporation, and others.


By Technology

By Application

By End-Use

By Region

  • Microarray

  • Polymerase Chain Reaction (PCR)

  • Sanger Sequencing

  • Next-Generation Sequencing

  • Others


  • Cardiovascular Disease

  • Cancer

  • Tuberculosis

  • Alzheimer Disease

  • Others



  • Pharmacogenomics Service Provider

  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the  Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the  Rest of APAC)

  • Latin America(Brazil, Mexico, and Rest of Latin America)

  • Middle East of Africa (GCC, South Africa, and the  Rest of the Middle East & Africa)

Key Industry Development

The increasing ubiquity of chronic diseases like cancer and neurological diseases encourages the demand for the precise combination of drugs in the form of medicine.

  • In June 2022, Bio-Rad launched a SEQuoia Express Stranded RNA Library Prep Kit at Advances in Genome Biology and Technology (AGBT). The kit provides an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling.

  • In February 2022, Agilent Technologies announced the partnership with Element Biosciences to validate the AVITI system with SureSelect hybrid-capture target enrichment solutions, a pre-sequencing DNA preparation method.

  • In April 2018, ThermoFisher Scientific with the University of Pittsburgh established the pharmacogenomics center to enhance the scope of research & development in genomics, bioinformatics, and others. This center accelerated the innovation of personalized medicine in the market.

  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients


Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.